| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698235 | Clinical Oncology | 2014 | 26 Pages |
Abstract
The published data support the use of combined treatment with androgen deprivation and radiotherapy for intermediate- and high-risk localised and locally advanced prostate cancer. Optimal timing, duration, formulation and the management of side-effects remain important questions for further research.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Schmidt-Hansen, P. Hoskin, P. Kirkbride, E. Hasler, N. Bromham,